Drug intelligence / Profile preview

IVL2004

Development stage: Preclinical
Lead developer: Virbac
Modality: Small Molecules
Administration: Parenteral

Overview

IVL2004 is a long-acting injectable (LAI) small molecule formulation being developed by Inventage Lab, in partnership with Virbac, for the prevention of heartworm in the veterinary market. The product utilizes Inventage Lab's proprietary IVL-DrugFlow microsphere technology to enable a sustained-release profile, aiming to provide long-term protection with a single administration. It is currently in the preclinical stage of development.

Beyond the preview

Go deeper on IVL2004.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IVL2004.

Explore the full profile